Results 31 to 40 of about 1,353,059 (301)

Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter use

Pulmonary Circulation, 2019
A 36-year-old woman presented with recurrent pulmonary emboli (PE) despite oral anticoagulation. She was a type I diabetic with severe gastroparesis requiring insertion of multiple long-term peripherally inserted central catheters (PICC) over a 10-year ...
Abigail Masding, Stephen D. Preston, Mark Toshner, Joseph Barnett, Carl Harries, Konstantinos Dimopoulos, Aleksander Kempny, Colm McCabe, David P. Jenkins, S. John Wort, Laura C. Price   +10 more
doaj   +1 more source

Macitentan in daily clinical practice: A single centre, 1-year experience

Pulmonology, 2018
The effectiveness and safety of macitentan, a dual endothelin-receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH), were shown in an extensive clinical trial oriented towards morbidity and mortality events.
S. Cadenas-Menéndez, P. Álvarez-Vega, J. Martín-Moreiras, M. Barreiro-Pérez, M.Á. Gómez-Sánchez, P.L. Sánchez-Fernández   +5 more
doaj   +3 more sources

Pulmonary Hypertension: Diagnosis, Management, and Treatment [PDF]

, 2019
2019-02Pulmonary hypertension (PH) is a hemodynamic state that is characterized by a resting mean pulmonary artery pressure ≧ 25 mmHg. The common forms of PH are pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH),
Okumura, Naoki, Kondo, Takahisa, Adachi, Shiro, Murohara, Toyoaki   +3 more
core   +1 more source

Pulmonary hypertension associated with left-sided heart disease

Swiss Medical Weekly, 2017
Pulmonary hypertension associated with left-sided heart disease (PH-LHD) is the most common type of pulmonary hypertension. In patients with left-sided heart disease, the presence of pulmonary hypertension is typically a marker of more advanced disease,
Micha T. Maeder, Otto D. Schoch, Rebekka Kleiner, Lucas Joerg, Daniel Weilenmann, Swiss Medical Weekly   +5 more
doaj   +1 more source

Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT)

Pulmonary Circulation, 2022
Even though pulmonary arterial hypertension (PAH) remains an incurable disease, the combination of PAH‐specific therapies allowed treatment strategies to evolve from symptom‐based ones to others that aim to move patients to low‐risk conditions ...
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi   +7 more
doaj   +1 more source

Definitions and Diagnosis of Pulmonary Hypertension [PDF]

, 2013
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition.
Satoh, T., Bogaard, Harm Jan, Kurzyna, M., Wilkins, M.R., Frantz, R., Langleben, David, Khanna, Dinesh, Manes, Alessandra, Bogaard, H.J., Khanna, D., Badesch, David B., Hoeper, Marius M., Kurzyna, Marcin, Torres, F., Hoeper, M.M., Satoh, Toru, Wilkins, Martin R., Torres, Fernando, Condliffe, R., Langleben, D., Badesch, D.B., Frantz, Robert, Condliffe, Robin, Manes, A.   +23 more
core   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives.

, 2022
Pulmonary hypertension is an heterogeneous group of diseases characterised by increased pulmonary arterial pressures which impact on the upstream right ventricle.
Chaouat, A., Schwitter, J., Aubert, J.D., Lechartier, B.   +3 more
core   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients

BMC Pulmonary Medicine, 2019
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especially for people affected by pulmonary hypertension (PH).
Iain Armstrong, Catherine Billings, David G. Kiely, Janelle Yorke, Carl Harries, Shaun Clayton, Wendy Gin-Sing   +6 more
doaj   +1 more source